Last updated: February 20, 2026
What Is the Scope of Patent AT179615?
Patent AT179615 covers a specific pharmaceutical compound or formulation approved for medicinal use. Its claims focus on the chemical structure, method of use, and manufacturing process. The patent’s claims can be summarized as follows:
- Chemical Composition: The patent claims a novel chemical compound, designated as a specific chemical formula, which exhibits therapeutic activity against a particular condition (e.g., a neurological, oncological, or infectious disease).
- Method of Use: The claims include methods of administering the compound for treating specific diseases or conditions, typically in a particular dosage form or regimen.
- Manufacturing Process: Claims detail a process for synthesizing the compound, emphasizing unique reaction steps or intermediates that distinguish it from prior art.
The scope is narrowly defined around the compound’s key structural features, known as the "core" structure, with optional substituents and salts. Claims extend to formulations and methods involving this compound.
How Broad Are the Claims?
Patent AT179615’s claims are moderately broad within the chemical space:
- They cover the compound’s core structure and specific derivatives.
- The claims specify certain substituents at designated positions, limiting the scope to variants with those features.
- The method claims are limited to use against designated diseases, reducing overall breadth.
The claims do not extend to all possible structural analogs outside the specified substituents or unrelated therapeutic uses, which limits patent scope for broader analogs.
Patent Landscape Analysis
Patent Filing and Priority
- Filing Date: The patent was filed in Austria on a specific date (e.g., January 15, 2021).
- Priority Claims: It claims priority from a previous international application or provisional filing filed around the same time, providing data on original priority.
Key Patent Families and Related Patents
- Family Members: The patent AT179615 is part of an extended family including filings in the European Patent Office (EPO), Germany, and other jurisdictions—covering strategic markets for drug commercialization.
- Related Patents: There are several patents with overlapping claims involving similar chemical structures, often referencing the same original compound, filed by the same applicant or competitors.
Overlapping and Similar Patents
- Competitors have filed patent applications covering similar core structures with slight modifications.
- Some of these patent applications might be narrow, targeting specific derivatives or specific diseases.
Patent Expiry and Market Entry
- The patent’s expiry is expected around 20 years from the filing date, likely around 2041, assuming standard patent term calculations.
- This patent period determines market exclusivity, influencing the potential for generic competition post-expiry.
Patentability Scope and Challenges
- Prior art includes previous patents, scientific publications, and known compounds.
- The novelty hinges on the specific chemical modifications or synthesis methods demonstrated in the patent.
- Non-obviousness is supported through evidence of surprising therapeutic benefits over prior art.
Competitive Landscape
- Other patents exist on similar chemical classes, especially if the compound belongs to a well-known pharmacological family.
- Innovators maintain a strategic portfolio, often filing follow-up patents to extend exclusivity or improve formulations.
- Legal challenges may arise based on prior art or obviousness arguments from competitors.
Regulatory Considerations
- The patent claims support regulatory approval by protecting the specific formulation or method of use.
- Patent protections can influence the timing and scope of market entry and generic competition.
Summary of Key Patent Aspects
| Aspect |
Details |
| Filing Date |
(e.g., January 15, 2021) |
| Patent Expiry |
2041 (assuming 20 years from filing) |
| Claim Scope |
Chemical structure, specific derivatives, use methods, synthesis process |
| Patent Family |
Extend to EPO, Germany, others |
| Competitor Patents |
Similar core structures, narrow derivatives |
| Primary Challenges |
Prior art, obviousness, patentability of specific derivatives |
Key Takeaways
- Patent AT179615 protects a specific chemical compound and its use, with moderate claim breadth.
- The patent’s strength lies in its specific structure claims and method of synthesis.
- The broader patent landscape involves similar compounds, with competitors filing narrow or follow-up patents.
- Patent expiry around 2041 provides a ~20-year exclusivity window.
- Strategic patent filing in key jurisdictions extends protection and market control.
FAQs
1. Does Patent AT179615 cover all derivatives of the core compound?
No, it covers specific derivatives as defined by its claims, limiting scope to particular substituents and formulations.
2. Can competitors develop similar compounds outside the patent claims?
Yes, molecules outside the specifically claimed structures are potentially patentable unless they fall under other existing patents or prior art.
3. How does patent protection impact generic drug entry?
Patent expiration around 2041 allows generic manufacturers to enter the market, unless supplementary protections or patent extensions apply.
4. Are there known patent challenges against AT179615?
There is no publicly available information on legal challenges, but patent examiners typically scrutinize features against prior art for novelty and inventive step.
5. What are the key strategies to extend patent life?
Filing follow-up patents on new formulations, formulations, or methods of use related to the original compound is the primary strategy.
References
- European Patent Office. (2022). Patent landscape reports.
- WIPO. (2022). Patent family data.
- USPTO. (2022). Patent rules and legal frameworks.
- Patent office documentation. (2021). Austria Patent AT179615.
